
Derek Douglas Knight
Examiner (ID: 5703, Phone: (571)272-7951 , Office: P/3659 )
| Most Active Art Unit | 3659 |
| Art Unit(s) | 3659, 3655, 3681 |
| Total Applications | 1137 |
| Issued Applications | 957 |
| Pending Applications | 48 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6550822
[patent_doc_number] => 20100233198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'USE OF OLIGOSACCHARIDES CONTAINING N-ACETYLLACTOSAMINE FOR MATURATION OF IMMUNE RESPONSES IN NEONATES'
[patent_app_type] => utility
[patent_app_number] => 12/741997
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3785
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233198.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741997
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741997 | USE OF OLIGOSACCHARIDES CONTAINING N-ACETYLLACTOSAMINE FOR MATURATION OF IMMUNE RESPONSES IN NEONATES | Nov 6, 2008 | Abandoned |
Array
(
[id] => 6495890
[patent_doc_number] => 20100286085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'NOVEL CHONDROITIN SULFATE HAVING DECREASED MOLECULAR WEIGHT AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/680995
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7054
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286085.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680995 | NOVEL CHONDROITIN SULFATE HAVING DECREASED MOLECULAR WEIGHT AND USE THEREOF | Sep 30, 2008 | Abandoned |
Array
(
[id] => 6320915
[patent_doc_number] => 20100196455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/598830
[patent_app_country] => US
[patent_app_date] => 2008-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14461
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196455.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598830
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598830 | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof | May 1, 2008 | Abandoned |
Array
(
[id] => 6618750
[patent_doc_number] => 20100099861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'SEPARATING AGENT FOR OPTICAL ISOMER'
[patent_app_type] => utility
[patent_app_number] => 12/450947
[patent_app_country] => US
[patent_app_date] => 2008-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17490
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099861.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450947 | SEPARATING AGENT FOR OPTICAL ISOMER | May 1, 2008 | Abandoned |
Array
(
[id] => 6327101
[patent_doc_number] => 20100197625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'SYNTHETIC LIPOPHILIC INOSITOL GLYCANS FOR TREATMENT OF CANCER AND GLUCOSE-METABOLISM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/519818
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 25148
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197625.pdf
[firstpage_image] =>[orig_patent_app_number] => 12519818
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519818 | SYNTHETIC LIPOPHILIC INOSITOL GLYCANS FOR TREATMENT OF CANCER AND GLUCOSE-METABOLISM DISORDERS | Dec 20, 2007 | Abandoned |
Array
(
[id] => 6629810
[patent_doc_number] => 20100311674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS WITH A MECHANISM OF MULTI-TARGET RECEPTOR RETROACTION FOR TREATING DEPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/745459
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11463
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12745459
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745459 | PHARMACEUTICAL COMPOSITIONS WITH A MECHANISM OF MULTI-TARGET RECEPTOR RETROACTION FOR TREATING DEPRESSION | Nov 29, 2007 | Abandoned |
Array
(
[id] => 6103095
[patent_doc_number] => 20110166530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'HYALURONIC ACID DISPERSION, PRODUCTION AND USE'
[patent_app_type] => utility
[patent_app_number] => 12/309467
[patent_app_country] => US
[patent_app_date] => 2007-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3027
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12309467
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309467 | HYALURONIC ACID DISPERSION, PRODUCTION AND USE | Jul 24, 2007 | Abandoned |
Array
(
[id] => 5466016
[patent_doc_number] => 20090326216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'PROCESS FOR ACYLATING CELLULOSE'
[patent_app_type] => utility
[patent_app_number] => 12/305017
[patent_app_country] => US
[patent_app_date] => 2007-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13259
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0326/20090326216.pdf
[firstpage_image] =>[orig_patent_app_number] => 12305017
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305017 | PROCESS FOR ACYLATING CELLULOSE | Jun 3, 2007 | Abandoned |
Array
(
[id] => 5614581
[patent_doc_number] => 20060116509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Manufacture of limonoid compounds'
[patent_app_type] => utility
[patent_app_number] => 11/289240
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11044
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116509.pdf
[firstpage_image] =>[orig_patent_app_number] => 11289240
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/289240 | Manufacture of limonoid compounds | Nov 28, 2005 | Abandoned |
Array
(
[id] => 8232821
[patent_doc_number] => 08198261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Thermally modified microbial-derived cellulose for in vivo implantation'
[patent_app_type] => utility
[patent_app_number] => 10/920297
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5407
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920297 | Thermally modified microbial-derived cellulose for in vivo implantation | Aug 17, 2004 | Issued |
Array
(
[id] => 7276433
[patent_doc_number] => 20040235884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Preventives/remedies for cholinergic neuropathy'
[patent_app_type] => new
[patent_app_number] => 10/486051
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7170
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486051
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486051 | Preventives/remedies for cholinergic neuropathy | Mar 1, 2004 | Abandoned |
Array
(
[id] => 7288094
[patent_doc_number] => 20040147480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds'
[patent_app_type] => new
[patent_app_number] => 10/757233
[patent_app_country] => US
[patent_app_date] => 2004-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 11744
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147480.pdf
[firstpage_image] =>[orig_patent_app_number] => 10757233
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/757233 | Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds | Jan 12, 2004 | Abandoned |
Array
(
[id] => 7127938
[patent_doc_number] => 20050059682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Compositions and methods for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/661386
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13705
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661386 | Compositions and methods for treatment of cancer | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7467975
[patent_doc_number] => 20040053891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => '5-(E)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/653538
[patent_app_country] => US
[patent_app_date] => 2003-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18505
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053891.pdf
[firstpage_image] =>[orig_patent_app_number] => 10653538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/653538 | 5-(E)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use | Sep 1, 2003 | Abandoned |
Array
(
[id] => 7379425
[patent_doc_number] => 20040028755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Use of CYP2D6 inhibitors in combination therapies'
[patent_app_type] => new
[patent_app_number] => 10/624123
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5310
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20040028755.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624123
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624123 | Use of CYP2D6 inhibitors in combination therapies | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7395873
[patent_doc_number] => 20040018253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Use of CYP2D6 inhibitors in combination therapies'
[patent_app_type] => new
[patent_app_number] => 10/622301
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5311
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018253.pdf
[firstpage_image] =>[orig_patent_app_number] => 10622301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/622301 | Use of CYP2D6 inhibitors in combination therapies | Jul 17, 2003 | Abandoned |
Array
(
[id] => 7437477
[patent_doc_number] => 20040002543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain'
[patent_app_type] => new
[patent_app_number] => 10/610386
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2172
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10610386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/610386 | Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain | Jun 29, 2003 | Abandoned |
Array
(
[id] => 7397828
[patent_doc_number] => 20040038954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Method of treating inflammatory conditions with progesterone or progesterone analogs'
[patent_app_type] => new
[patent_app_number] => 10/601756
[patent_app_country] => US
[patent_app_date] => 2003-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6018
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10601756
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/601756 | Method of treating inflammatory conditions with progesterone or progesterone analogs | Jun 23, 2003 | Abandoned |
Array
(
[id] => 6725579
[patent_doc_number] => 20030207891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Combination therapy for modulating the human sexual response'
[patent_app_type] => new
[patent_app_number] => 10/462888
[patent_app_country] => US
[patent_app_date] => 2003-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7644
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207891.pdf
[firstpage_image] =>[orig_patent_app_number] => 10462888
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/462888 | Combination therapy for modulating the human sexual response | Jun 16, 2003 | Abandoned |
Array
(
[id] => 6725537
[patent_doc_number] => 20030207849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'P38MAPK inhibitor and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/408968
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8054
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207849.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408968
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408968 | P38MAPK inhibitor and uses thereof | Apr 7, 2003 | Abandoned |